Impact of Tucatinib on Progression Free Survival in Patients with HER2+Metastatic Breast Cancer and Brain Metastases

被引:0
作者
Loibl, Sibylle [1 ]
Lin, Nancy [2 ]
Murthy, Rashmi K. [3 ]
Hurvitz, Sara A. [4 ]
Borges, Virginia [5 ]
Oliveria, Mafalda [6 ]
Oakman, Catherine [7 ]
Khan, Sarah [8 ]
Lynch, Cynthia [9 ]
Westbrook, Kelly [10 ]
Doyle, Catherine [11 ]
Reinisch, Mattea [12 ]
Callenoni, Marco [13 ]
Slamon, Dennis [4 ]
Hortobagyi, Gabriel [3 ]
Winer, Eric [2 ]
Ramos, Jorge [14 ]
Feng, Wentao [15 ]
Bachelot, Thomas [16 ]
机构
[1] GBG Forsch GmbH, Neu Isenburg, Germany
[2] Dana Farber Canc Inst, Boston, MA USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[4] UCLA Med Ctr, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA
[5] Univ Colorado, Ctr Canc, Aurora, CO USA
[6] Hosp Univ Vall Dhebron, Barcelona, Spain
[7] Sunshine Hosp, St Albans, Australia
[8] Nottingham Univ Hosp NHS Trust, Dept Oncol, Nottingham, England
[9] Goodyear, Western Reg Med Ctr, Canc Treatment Ctr Amer, Akron, OH USA
[10] Duke Univ, Med Ctr, Durham, NC USA
[11] Univ Laval, Hop St Sacrement, CHU Quebec, Laval, PQ, Canada
[12] Klin Essen Mitte Evang Huyssens Stiftung, Essen, Germany
[13] Ist Europeo Oncol, Milan, Italy
[14] Seagen Inc, Clin Dev, Bothell, WA USA
[15] Seagen Inc, Biostat, Bothell, WA USA
[16] Ctr Leon Berard, Lyon, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
309
引用
收藏
页码:26 / 26
页数:1
相关论文
共 1 条
[1]   Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer [J].
Murthy, R. K. ;
Loi, S. ;
Okines, A. ;
Paplomata, E. ;
Hamilton, E. ;
Hurvitz, S. A. ;
Lin, N. U. ;
Borges, V. ;
Abramson, V. ;
Anders, C. ;
Bedard, P. L. ;
Oliveira, M. ;
Jakobsen, E. ;
Bachelot, T. ;
Shachar, S. S. ;
Mueller, V. ;
Braga, S. ;
Duhoux, F. P. ;
Greil, R. ;
Cameron, D. ;
Carey, L. A. ;
Curigliano, G. ;
Gelmon, K. ;
Hortobagyi, G. ;
Krop, I. ;
Loibl, S. ;
Pegram, M. ;
Slamon, D. ;
Palanca-Wessels, M. C. ;
Walker, L. ;
Feng, W. ;
Winer, E. P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (07) :597-609